Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) have earned an average recommendation of “Hold” from the eight brokerages that are currently covering the company, Marketbeat reports. Seven analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $17.10.
A number of research firms recently issued reports on AFYA. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a research note on Monday, April 20th. Zacks Research cut Afya from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. decreased their price objective on Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a report on Monday, June 22nd. Wall Street Zen lowered shares of Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Bank of America reaffirmed a “neutral” rating on shares of Afya in a report on Thursday, June 11th.
Read Our Latest Analysis on Afya
Insider Buying and Selling at Afya
Institutional Trading of Afya
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Doma Perpetual Capital Management LLC boosted its holdings in Afya by 50.6% in the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after purchasing an additional 299,419 shares in the last quarter. Swedbank AB raised its stake in shares of Afya by 170.3% during the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock worth $2,916,000 after buying an additional 119,200 shares in the last quarter. Jump Financial LLC purchased a new position in shares of Afya during the 2nd quarter worth approximately $731,000. Qube Research & Technologies Ltd acquired a new stake in shares of Afya in the 3rd quarter valued at approximately $610,000. Finally, Pictet Asset Management Holding SA acquired a new stake in shares of Afya in the 4th quarter valued at approximately $508,000. 88.02% of the stock is owned by hedge funds and other institutional investors.
Afya Stock Performance
Shares of AFYA traded down $0.10 during midday trading on Friday, reaching $14.38. 63,386 shares of the stock were exchanged, compared to its average volume of 121,278. Afya has a twelve month low of $13.00 and a twelve month high of $16.50. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.78 and a quick ratio of 1.78. The company has a market capitalization of $1.35 billion, a price-to-earnings ratio of 9.40, a PEG ratio of 1.43 and a beta of 0.32. The business’s 50-day moving average price is $14.33 and its 200 day moving average price is $14.54.
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Read More
- Five stocks we like better than Afya
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
